Mostrando 3 resultados de: 3
Filtros aplicados
Subtipo de publicación
Other(3)
Publisher
Elsevier(3)
Área de conocimiento
Farmacología(2)
Origen
google(3)
Cost-effectiveness of bendamustine versus fludarabine for first-line treatment of chronic lymphocytic leukemia (Cll) in Colombia
OtherAbstract: Objectives To determine the cost-effectiveness of bendamustine versus fludarabine for first line trePalabras claves:Autores:CARMEN BAYAS ZAMBRANOFuentes:googleThe Cost-Effectiveness of Bendamustine-Rituximab Versus Fludarabine-Rituximab for Patients with Indolent Non-Hodgkin’s Lymphoma (INHL) Who Have Progressed Following Treatment …
OtherAbstract: Objectives To determine the cost-effectiveness of bendamustine-rituximab (Ben-R) versus fludarabine-Palabras claves:Autores:CARMEN BAYAS ZAMBRANOFuentes:googleThe cost-effectiveness of bendamustine-rituximab (BEN-R) versus R-CHOP for the first line treatment of patients with indolent non-Hodgkin’s lymphoma (INHL) in Colombia
OtherAbstract: Objectives To determine the cost-effectiveness of Ben-R versus R-CHOP for the first-line treatment oPalabras claves:Autores:CARMEN BAYAS ZAMBRANOFuentes:google